Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,661
Sort by:

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For e...

February 2023 140 pages

Peritonitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Peritonitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Peritonitis pipeline candid...

February 2023 50 pages

Pertussis (Whooping Cough) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pertussis (Whooping Cough) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pertussis (W...

February 2023 130 pages

Phenylketonuria (PKU) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Phenylketonuria (PKU) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Phenylketonuria (...

February 2023 110 pages

Pheochromocytoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pheochromocytoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pheochromocytoma pipel...

February 2023 60 pages

Pigmented Villonodular Synovitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pigmented Villonodular Synovitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pigmen...

February 2023 40 pages

Pituitary ACTH Hypersecretion (Cushing Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pituitary ACTH Hypersecretion (Cushing Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For eac...

February 2023 40 pages

Plague Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Plague Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Plague pipeline candidate, detai...

February 2023 40 pages

Poliomyelitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Poliomyelitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Poliomyelitis pipeline ca...

February 2023 100 pages

Polycystic Kidney Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Polycystic Kidney Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Polycystic Ki...

February 2023 150 pages

Polycystic Ovarian Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Polycystic Ovarian Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Polycystic...

February 2023 60 pages

Polycythemia Vera Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Polycythemia Vera Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Polycythemia Vera pip...

February 2023 80 pages

Pompe Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pompe Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pompe Disease pipeline ca...

February 2023 130 pages

Pontine Glioma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pontine Glioma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pontine Glioma pipeline...

February 2023 190 pages

Post Menopausal Osteoporosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Post Menopausal Osteoporosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Post Menop...

February 2023 200 pages

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each...

February 2023 150 pages

Prader-Willi Syndrome (PWS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Prader-Willi Syndrome (PWS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Prader-Will...

February 2023 110 pages

Premature Labor (Tocolysis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Premature Labor (Tocolysis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Premature L...

February 2023 50 pages

Presbyopia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Presbyopia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Presbyopia pipeline candidat...

February 2023 90 pages

Pressure Ulcers Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pressure Ulcers Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pressure Ulcers pipelin...

February 2023 40 pages

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023....

February 2023 150 pages

Primary Immune Deficiency (PID) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Primary Immune Deficiency (PID) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Primary...

February 2023 130 pages

Primary Sclerosing Cholangitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Primary Sclerosing Cholangitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Primary...

February 2023 120 pages

Progressive Multifocal Leukoencephalopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Progressive Multifocal Leukoencephalopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of...

February 2023 50 pages

Progressive Supranuclear Palsy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Progressive Supranuclear Palsy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Progress...

February 2023 120 pages

Proliferative Diabetic Retinopathy (PDR) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Proliferative Diabetic Retinopathy (PDR) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of th...

February 2023 40 pages

Proliferative Vitreoretinopathy (PVR) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Proliferative Vitreoretinopathy (PVR) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the P...

February 2023 40 pages

Prosthetic Joint Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Prosthetic Joint Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Prosthetic...

February 2023 60 pages

Pruritus Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pruritus Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pruritus pipeline candidate, d...

February 2023 200 pages

Pseudomonas aeruginosa Pneumonia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pseudomonas aeruginosa Pneumonia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pseudo...

February 2023 40 pages

Pulmonary Embolism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pulmonary Embolism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pulmonary Embolism p...

February 2023 50 pages

Pyelonephritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pyelonephritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pyelonephritis pipeline...

February 2023 80 pages

Rabies Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rabies Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rabies pipeline candidate, detai...

February 2023 140 pages

Radiodermatitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Radiodermatitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Radiodermatitis pipelin...

February 2023 80 pages

Rectal Cancer Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rectal Cancer Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rectal Cancer pipeline ca...

February 2023 190 pages

Recurrent Malignant Glioma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Recurrent Malignant Glioma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Recurrent Ma...

February 2023 50 pages

Reflux Esophagitis (Gastroesophageal Reflux Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Reflux Esophagitis (Gastroesophageal Reflux Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. Fo...

February 2023 130 pages

Resistant Pseudomonas aeruginosa Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Resistant Pseudomonas aeruginosa Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of...

February 2023 50 pages

Restenosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Restenosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Restenosis pipeline candidat...

February 2023 40 pages

Restless Legs Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Restless Legs Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Restless Legs Sy...

February 2023 40 pages

Retinal Vein Occlusion Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Retinal Vein Occlusion Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Retinal Vein Occ...

February 2023 140 pages

Retinoblastoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Retinoblastoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Retinoblastoma pipeline...

February 2023 60 pages

Retinopathy of Prematurity Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Retinopathy of Prematurity Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Retinopathy...

February 2023 90 pages

Rett Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rett Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rett Syndrome pipeline ca...

February 2023 200 pages

Rhinovirus Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rhinovirus Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rhinovirus Infect...

February 2023 120 pages

Rosacea Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rosacea Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rosacea pipeline candidate, det...

February 2023 110 pages

Rotavirus Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rotavirus Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rotavirus Infectio...

February 2023 90 pages

Rubella (German Measles) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rubella (German Measles) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rubella (Germa...

February 2023 50 pages

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of...

February 2023 40 pages

Sarcopenia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sarcopenia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Sarcopenia pipeline candidat...

February 2023 140 pages

Filters

Search

Categories

808
26
203
153
138
134
125
90
65,562
803
720
776
123

Publishers

179
1
239
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
376
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
60
1,696
8
8,921
2,213
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
306
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
703
26
136
525
174
622
64,677

Price

Date

Pages

Offers

1
280
1
1